|
Mar 26
|
CHMP to Delay Nod on Biogen (BIIB), Eisai's Alzheimer's Drug
|
|
Mar 26
|
ANI Pharmaceuticals, Inc. (ANIP) Hits Fresh High: Is There Still Room to Run?
|
|
Mar 23
|
NYCB, Vista Outdoor, Cardlytics, and More Stocks See Action From Activist Investors
|
|
Mar 22
|
Novo Nordisk (NVO) Gets Positive CHMP Opinion for Insulin Icodec
|
|
Mar 22
|
Merck's (MRK) Keytruda-Lynparza Combo Fails 2nd Lung Cancer Study
|
|
Mar 21
|
Lifecore (LFCR) Down 30% on Ending Strategic Review With No Deal
|
|
Mar 21
|
ACELYRIN (SLRN) Up on Data From Thyroid Eye Disease Study
|
|
Mar 20
|
Axsome (AXSM) Begins Dosing in Depression Study on Sunosi
|
|
Mar 20
|
ANI (ANIP) Is Considered a Good Investment by Brokers: Is That True?
|
|
Mar 19
|
ANI Pharmaceuticals (ANIP) Gains But Lags Market: What You Should Know
|
|
Mar 19
|
Intellia (NTLA) Begins Dosing in Phase III ATTR Amyloidosis Study
|
|
Mar 18
|
Cybin (CYBN) Begins Phase II Study on Anxiety Drug, Stock Up
|
|
Mar 18
|
Immuneering (IMRX) Plummets 71% in One Week: Here's Why
|
|
Mar 15
|
Allogene's (ALLO) Q4 Loss Narrower Than Expected, Sales Miss
|
|
Mar 14
|
Is ANI Pharmaceuticals (ANIP) Stock Outpacing Its Medical Peers This Year?
|
|
Mar 13
|
Regulus (RGLS) Up 71% on Topline Data from Kidney Disease Study
|
|
Mar 12
|
Why Moderna (MRNA) Stock Price Was Up 9% on Monday
|
|
Mar 11
|
Amylyx's (AMLX) ALS Drug Fails Pivotal Study, Stock Down 82%
|
|
Mar 9
|
ANI Pharmaceuticals Inc CEO Nikhil Lalwani Sells 45,257 Shares
|
|
Mar 8
|
MindMed's (MNMD) Anxiety Drug Gets FDA Breakthrough Therapy Tag
|